Hepatology, Gallbladder, and Biliary Tract Diseases Project Mission Statement: Difference between revisions
Jump to navigation
Jump to search
YazanDaaboul (talk | contribs) No edit summary |
No edit summary |
||
(One intermediate revision by the same user not shown) | |||
Line 7: | Line 7: | ||
==''WikiDoc Oncology Project'' — Mission Statement== | ==''WikiDoc Oncology Project'' — Mission Statement== | ||
*Thank you for your interest in the ''WikiDoc Hepatology, Gallbladder, and Biliary Tract Diseases Project''. | |||
*The project aims to integrate current body of medical literature into treatment strategies for non-infectious, non-oncologic hepatic, gallbladder, and bilary tract diseases, in conformity with practice guidelines, consensus statements, systematic reviews, and expert opinions. | |||
*Educational content provided herein is not intended to supplant but supplement clinical judgment. | |||
*Please let us know if there is additional information you would like to see included. We welcome your comments at [mailto:ydaaboul@wikidoc.org this email address.] | |||
</div> | </div> |
Latest revision as of 16:43, 28 February 2020
Hepatology, Gallbladder, and Biliary Tract Diseases Project |
---|
Mission Statement |
Textbook Outline |
List of Chapters & Priority (Table) |
Checklist (Download) |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Yazan Daaboul, M.D.; Serge Korjian M.D.
WikiDoc Oncology Project — Mission Statement
- Thank you for your interest in the WikiDoc Hepatology, Gallbladder, and Biliary Tract Diseases Project.
- The project aims to integrate current body of medical literature into treatment strategies for non-infectious, non-oncologic hepatic, gallbladder, and bilary tract diseases, in conformity with practice guidelines, consensus statements, systematic reviews, and expert opinions.
- Educational content provided herein is not intended to supplant but supplement clinical judgment.
- Please let us know if there is additional information you would like to see included. We welcome your comments at this email address.